Log in
Enquire now
‌

US Patent 10919982 Antibodies to symmetrically dimethylated arginine analytes and use thereof

Patent 10919982 was granted and assigned to Ark Diagnostics, Inc. on February, 2021 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent
0

Patent attributes

Patent Applicant
Ark Diagnostics, Inc.
Ark Diagnostics, Inc.
0
Current Assignee
Ark Diagnostics, Inc.
Ark Diagnostics, Inc.
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
109199820
Patent Inventor Names
Johnny Valdez0
Byung Sook Moon0
Ki Chung0
Yunfei Chen0
Date of Patent
February 16, 2021
0
Patent Application Number
169079320
Date Filed
June 22, 2020
0
Patent Citations Received
‌
US Patent 11384158 Antibodies to symmetrically dimethylated arginine analytes and use thereof
0
‌
US Patent 11459403 Antibodies to symmetrically dimethylated arginine analytes and use thereof
Patent Primary Examiner
‌
Maher M. Haddad
0
Patent abstract

Disclosed is an antibody which binds to a symmetrically dimethylated arginine analyte that can be used to detect a symmetrically dimethylated arginine analyte in a sample, such as in a homogeneous enzyme immunoassay method.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 10919982 Antibodies to symmetrically dimethylated arginine analytes and use thereof

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.